Hypertension in Children and Adolescents, 1st ed. 2019
New Perspectives

Updates in Hypertension and Cardiovascular Protection Series

Coordinators: Lurbe Empar, Wühl Elke

Language: English

89.66 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Hypertension in Children and Adolescents
Publication date:
Support: Print on demand

126.59 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Hypertension in children and adolescents
Publication date:
277 p. · 15.5x23.5 cm · Hardback
This book is devoted to hypertension in children and adolescents, a clinical issue that ? thanks to the strides made in several areas of pathophysiological and clinical research ? has received growing interest in cardiovascular medicine over the last several years.

Given the increasing prevalence of hypertension in children and adolescents, this book represents an important and useful tool to address what has become a significant public health issue. It covers a diverse range of topics, from advances in the definition of hypertension and the identification of new risk factors, to current treatment strategies.

The book also presents an overview of the latest findings, including the clinical significance of isolated systolic hypertension (ISH) in youth, the importance of out-of-office and central blood pressure measurement, new methods for assessing vascular phenotypes, and clustering of CV risk factors.

Gathering contributions by international experts and pursuing a practice-oriented approach, the book offers a valuable tool for cardiologists, pediatricians and nephrologists, as well as general practitioners.


1 ​Introduction.- 2 From pregnancy to childhood and adulthood: The trajectory of hypertension.- 3 Perinatal programing and blood pressure.- 4 Worldwide overview about the prevalence and trends of hypertension in Children and Adolescents.- 5 Office and out of office blood pressure measurements.- 6 Large vessels in hypertension: Central blood pressure.- 7 Isolated systolic hypertension.- 8 Secondary hypertension: Diagnostic and treatment.- 9 Monogenic hypertension.- 10 Neonatal hypertension.- 11 The heart in hypertension.- 12 The kidney in hypertension.- 13 No pharmacological treatment of hypertension.- 14Pharmacological approach to hypertension treatment.- 15 Physical exercise in the treatment of obesity: New approach to individualize treatment.- 16 Treatment of hypertension in chronic kidney disease.- 17 Long term follow up.- 18 Clinical trials

Empar Lurbe, MD, pHD, graduated from the Medical College of Valencia in 1976. She subsequently trained in pediatrics at the Hospital La Fe in Valencia. She completed her pediatric nephrology and hypertension fellowship at Northwestern University in Chicago, Illinois, in 1992.
In addition to practicing clinical pediatric nephrology at Valencia, she is also Head of the Pediatric Department and the Pediatric Unit against Obesity and Cardiovascular Risk in Children and Adolescents. Her research interests have led her to focus on epidemiologic studies of CV risk factors in children. She initiated the 24-hour ambulatory blood pressure and supervised collection of CV data for over two decades.
Dr. Lurbe is a Full Professor at Valencia University and became Head of Group at CIBERobn, Instituto de Salud Carlos III in 2006. This new opportunity allowed her to concentrate her clinical practice on the diagnosis and treatment of high blood pressure and obesity. She has since continued her research, focusing on non-invasive methods for measuring atherosclerosis, especially vascular function abnormalities, using Carotid Ultrasound, Arterial Stiffness and Endothelial Function. Her current research includes the application of 24- hour ambulatory blood pressure central BP and these new techniques to study the roles that pre- and post-natal nutrition, obesity, high blood pressure, cholesterol and diabetes play in the development of hardening of the arteries.

Dr. Elke Wühl is Professor of Pediatrics and consultant pediatric nephrologist at the Center of Pediatric and Adolescent Medicine, University of Heidelberg, Germany.

She received her doctorate (Dr. med.) from Heidelberg University Medical School and completed her residency and pediatric nephrology training at the University Children’s Hospital Heidelberg. She is certified pediatric nephrologist and hypertension specialist (DHL).

Dr. Wühl has special interest in progressio

Shares new insights into a significant public health issue Illustrates the latest findings from the benchmark applied to clinical practice Presents advances in defining hypertension and identifying new risk factors